One of RVX's peer Amarin just lost a court decision on generics being made for vascepa
I wonder if that helps RVX case for being a better buyout option for a BP, I definately say yes to that!!
https://ca.finance.yahoo.com/news/amarin-comments-ruling-vascepa-anda-222532146.html